Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-13 to 2024-02-14
Current total value of award: $300.5
Description: 4563640329!CLONAZEPAM 0.5 MG TABLET UD 100S